id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-P-0473-0011,FDA,FDA-2011-P-0473,Determination That the OXYCONTIN (oxycodone hydrochloride) Drug Products Covered by New Drug Application 20-553 Were Withdrawn From Sale for Reasons of Safety or Effectiveness,Notice,General Notice,2013-04-18T04:00:00Z,2013,4,2013-04-18T04:00:00Z,,2013-05-01T15:16:35Z,2013-09092,0,0,0900006481299dce
FDA-2011-P-0473-0010,FDA,FDA-2011-P-0473,"FDA/CDER to Varam, Inc. c/o: KVK-Tech, Inc. -  Agency Response",Other,Agency Response,2013-04-17T04:00:00Z,2013,4,2013-04-17T04:00:00Z,,2013-04-17T20:44:39Z,,0,0,09000064812984b4